预混与手混硅酸钙基生物陶瓷材料用于不可逆性牙髓炎恒牙牙髓切断术的系统综述与Meta分析
该系统综述与Meta分析纳入6项随机对照试验共499颗恒牙,比较预混与手混硅酸钙基材料在不可逆性牙髓炎牙髓切断术中的临床成功率。结果显示6个月和12个月随访时两组风险差均无临床意义差异,统计学等效性成立,证据确定性为中等。
要点
- 预混与手混硅酸钙基材料在不可逆性牙髓炎恒牙牙髓切断术后6个月和12个月临床成功率等效。
- 材料选择可基于操作特性、临床偏好、可及性和成本等实际因素,而非预期临床疗效优势。
- 证据确定性评为中等,支持两种材料在临床结局上无差异。
核心结论
- 预混与手混硅酸钙基生物陶瓷材料在不可逆性牙髓炎恒牙牙髓切断术后表现出临床等效的结局。
研究设计与样本
- 系统综述与Meta分析,遵循PRISMA 2020指南,PROSPERO注册号CRD420251110977,检索至2025年8月。
- 纳入6项随机对照试验,共499颗恒牙,比较预混与手混硅酸钙基材料在不可逆性牙髓炎牙髓切断术中的应用。
主要发现
- 6个月随访风险差RD=0.016(95%CI:-0.039至0.071),12个月随访RD=0.004(95%CI:-0.053至0.061),异质性可忽略(I2=0%)。
- 贝叶斯分析显示中等证据支持无治疗差异的零假设(6个月BF01=4.20;12个月BF01=3.67),证据确定性评为中等。
关键数值与推荐
- 等效性界值预设为±10%,采用两单侧检验评估统计学等效性。
- 风险差为0.016(95%CI:-0.039至0.071)在6个月,0.004(95%CI:-0.053至0.061)在12个月,均落入±10%等效界值内。
临床怎么用
- 在不可逆性牙髓炎恒牙牙髓切断术中,预混与手混硅酸钙基材料临床疗效等效,选择可依据操作特性、临床偏好、可及性和成本等实际因素决定。
局限性
- 证据确定性评为中等,纳入研究数量有限(6项随机对照试验)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Calcium silicate-based bioceramic materials are widely used in vital pulp therapy because of their favorable biological and sealing properties. Premixed formulations were introduced to reduce operator-dependent variability associated with manually mixed materials; however, their comparative clinical performance in irreversible pulpitis remains unclear. OBJECTIVES: To compare the clinical success of premixed versus manually mixed calcium silicate-based bioceramic materials used for pulpotomy procedures in permanent teeth with irreversible pulpitis. METHODS: This systematic review and meta-analysis was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines and registered in PROSPERO (CRD420251110977). Electronic databases were searched from inception to August 2025. Randomized controlled trials comparing premixed and manually mixed calcium silicate-based materials in pulpotomy procedures for permanent teeth with irreversible pulpitis were included. Random-effects meta-analysis was performed to calculate pooled risk differences (RDs) and 95% confidence intervals (CIs). Statistical equivalence was evaluated using the two one-sided tests procedure with a predefined equivalence margin of ±10%. Bayesian analysis and multiple sensitivity analyses were additionally performed. Risk of bias was assessed using risk of bias 2 tool, and certainty of evidence was evaluated using Grading of Recommendations Assessment, Development and Evaluation. RESULTS: Six randomized controlled trials involving 499 permanent teeth were included. No clinically meaningful differences were observed between premixed and manually mixed formulations at either 6 months (RD = 0.016; 95% CI: -0.039 to 0.071) or 12 months (RD = 0.004; 95% CI: -0.053 to 0.061), with negligible heterogeneity across analyses (I2 = 0%). Two one-sided tests analyses confirmed statistical equivalence at both follow-up periods (P < .001), with confidence intervals remaining entirely within the predefined ±10% equivalence margin. Bayesian analysis demonstrated moderate evidence favoring the null hypothesis of no treatment difference (BF01 = 4.20 at 6 months; BF01 = 3.67 at 12 months). Certainty of evidence was rated as moderate. CONCLUSION: Premixed and manually mixed calcium silicate-based bioceramic materials demonstrated clinically equivalent outcomes following pulpotomy in permanent teeth with irreversible pulpitis. Given their comparable clinical performance, material selection may reasonably be guided by practical considerations such as handling characteristics, clinician preference, availability, and cost rather than expectations of superior clinical effectiveness.
引用
- Sebastao De Souza H, Fernandes M, de Noronha de Ataide I, et al. Premixed Versus Manually Mixed Calcium Silicate-based Bioceramic Materials for Pulpotomy of Permanent Teeth with Irreversible Pulpitis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. J Endod. 2026. PMID: 42498036. doi:10.1016/j.joen.2026.07.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。